Warren Buffett’s Berkshire Hathaway reveals new stakes in Paramount, Citigroup

OMAHA, Neb. — Warren Buffett’s company on Monday revealed all the investment moves it made in the first quarter, when it spent more than $51 billion on stocks. But Buffett had already shared the biggest investments with Berkshire Hathaway BRK.A, -0.16% BRK.B, -0.34% shareholders at the company’s recent annual meeting. That means investors already knew that … Read more

These 6 ‘Dividend Aristocrats’ Have a Strong Pipeline for Cash. That’s a Plus.

Exxon Mobil is among the companies whose yield on free cash flow indicates strong support for the payout’s resilience. Here, an Exxon refinery in Rotterdam, Netherlands. Dean Mouhtaropoulos/Getty Images Text size Quarterly dividend payments can be a lifeline for investors who depend on income, retirees in particular. Those cash payments, however, don’t just appear out … Read more

Stocks for the Recession That May—or May Not—Be Coming

Text size Exelon stock offers a little bit of offense to go with its defense. Dreamstime The yield curve briefly inverted this past week—and that’s a recession signal that is either like Paul Revere’s ride or the boy who cried wolf. The good news: Investors don’t need to decide which just yet. The yield curve … Read more

AT&T’s Dividend Cut Puts It in an Unenviable Club

A company cutting its dividend after a spinoff is uncommon, but not unprecedented. The longer-term outcomes can vary markedly. AT&T (ticker: T) joined this club on Tuesday, when it said it expects that its annual dividend will be $1.11 a share, down sharply from $2.08 in 2021, after its planned spinoff of its WarnerMedia assets … Read more

AbbVie’s stock gains on fourth-quarter earnings as it reports better-than-expected sales of Humira

An earlier version of this report referred to Humana in the headline, not Humira. It has been corrected. Shares of AbbVie Inc. ABBV, +0.08% gained 1.4% in premarket trading on Wednesday after the company beat earnings expectations and generated more sales than expected of its top-selling rheumatoid arthritis drug, Humira. AbbVie had earnings of $4.0 … Read more